Join the club for FREE to access the whole archive and other member benefits.

Longevity Technology

Daily news and insights on research, investments and technologies on life extension

We bring together innovators and investors to commercialise the companies that will form the longevity economy.

There are already 100+ rejuvenation biotechs working on unique therapies and building R&D pipelines to increase healthspan and lifespan.

At the same time, all around the world, innovators are releasing nanobots, reprogramming nerve signals and applying AI to create exciting and scalable contributions to human Longevity.

Visit website: https://www.longevity.technology/

 LongevityTech

 longevitytechnology

 LongevityTech

Details last updated 12-Sep-2019

Longevity Technology News

Reason reports back from Rejuvenation Startup Summit 2024

Reason reports back from Rejuvenation Startup Summit 2024

Fight Aging! - 13-May-2024

A great summary of 25 speakers who are in various stages of platform building, drug discovery and clinical trials

Longevity now & next: Key findings and investment trends in 2023

Longevity now & next: Key findings and investment trends in 2023

Longevity Technology - 15-Apr-2024

Longevity.Technology releases its annual longevity investment report 2023

Big investors join First Longevity funding round

Big investors join First Longevity funding round

Longevity Technology - 16-Oct-2020

Key investors raise funding to support longevity sector

Longevity Technology is also referenced in the following:

Longevity Megatrend by Phil Newman

18-Jan-2023

Phil talks about shaping the longevity industry at this Oxford Society of Ageing and Longevity event (FREE)

Longevity Technology Creations

Leveraging the power of senolytics to eliminate senescence cells

Longevity Technology discusses senescent cells with Steve Matheson, CEO of Combilytics (YouTube)

People at Longevity Technology

Phil Newman

CEO & Founder Longevity.Technology

Laura Allison

Staff Writer and Marketing Executive at Longevity Technology

Beth Hyndman

Scientific writer at Longevity Technology

Daragh Campbell

Scientific Editor at Longevity Technology

Christos Evangelou

Medical Writer and Editor Nov20

Eleanor Garth

Staff Writer and Community Manager, Longevity Technology

Salvinija Roznyte

Salvinija Roznyte is journalist at Longevity.Technology

Articles sourced from Longevity Technology

AI-powered biotech Vivodyne aims to end animal testing with $40m funding boost

AI-powered biotech Vivodyne aims to end animal testing with $40m funding boost

Longevity Technology - 30-Jun-2025

Biotech firm uses AI and robotics to test drugs on real human tissues, not animals

Neuralink raised $600 million, reaching a $9 billion valuation

Neuralink raised $600 million, reaching a $9 billion valuation

Longevity Technology - 28-May-2025

The company is still in early stages but attracting strong investor interest

Altos Labs expands longevity portfolio with Dorian Therapeutics acquisition

Altos Labs expands longevity portfolio with Dorian Therapeutics acquisition

Longevity Technology - 23-May-2025

Dorian’s anti-senescence tech adds firepower to Altos Labs’ rejuvenation strategy

AI startup Somite raises $47m to revolutionize stem cell therapy

AI startup Somite raises $47m to revolutionize stem cell therapy

Longevity Technology - 16-May-2025

Somite AI uses DeltaStem to speed up and scale stem cell engineering

BrightFocus Foundation fuels early research on aging diseases with $13m grants

BrightFocus Foundation fuels early research on aging diseases with $13m grants

Longevity Technology - 13-May-2025

Private funding supports global scientists tackling Alzheimer’s, vision loss, and glaucoma

Rewriting the cell's code: HAYA’s mission to transform genomic medicine

Rewriting the cell's code: HAYA’s mission to transform genomic medicine

Longevity Technology - 12-May-2025

Biotech startup raises $65M to develop RNA therapies that reprogram disease-driving cell states

Hundred health acquires BellSant to supercharge AI longevity platform  strapline:

Hundred health acquires BellSant to supercharge AI longevity platform strapline:

Longevity Technology - 08-May-2025

AI-driven health platform gears up for launch with cutting-edge longevity data

NewLimit secures $130m to accelerate epigenetic reprogramming for longevity

NewLimit secures $130m to accelerate epigenetic reprogramming for longevity

Longevity Technology - 06-May-2025

The biotech company aims to target the root causes of ageing to develop therapies to extend lifespan

A brighter path for Parkinson’s: light therapy device nears FDA finish line

A brighter path for Parkinson’s: light therapy device nears FDA finish line

Longevity Technology - 28-Apr-2025

PhotoPharmics secures $6 million to advance its home-based Celeste device

Breakthrough drug targets liver regeneration with 21.5m boost

Breakthrough drug targets liver regeneration with 21.5m boost

Longevity Technology - 17-Apr-2025

HepaRegeniX advances trials for a novel liver regeneration therapy

Science corp secures major funding to restore sight with BCI tech

Science corp secures major funding to restore sight with BCI tech

Longevity Technology - 15-Apr-2025

A next-gen retinal implant offers new hope for vision loss from macular degeneration

New drug for Parkinson’s may keep symptoms under control with just weekly injections

New drug for Parkinson’s may keep symptoms under control with just weekly injections

Longevity Technology - 09-Apr-2025

It avoids common delivery problems and enters Phase 1 trials in 2025

Tribune Therapeutics secures 37m to tackle fibrosis at its source

Tribune Therapeutics secures 37m to tackle fibrosis at its source

Longevity Technology - 28-Mar-2025

Scandinavian biotech targets fibrosis with novel scar-blocking therapies

Mito Health raised $4 million to grow its AI-powered health platform

Mito Health raised $4 million to grow its AI-powered health platform

Longevity Technology - 18-Mar-2025

It uses blood tests to find early health risks and gives personalised advice

Augustine Therapeutics raises $84.8m for safer neuro and metabolic drugs

Augustine Therapeutics raises $84.8m for safer neuro and metabolic drugs

Longevity Technology - 12-Mar-2025

Clinical trials are beginning, backed by major investors like Novo Holdings

Trimtech secures $31m to tackle neurodegenerative diseases

Trimtech secures $31m to tackle neurodegenerative diseases

Longevity Technology - 06-Mar-2025

Targeted protein degradation tackles harmful aggregates while sparing healthy proteins

Tenaya raises $52.5m to push forward gene therapy trials

Tenaya raises $52.5m to push forward gene therapy trials

Longevity Technology - 05-Mar-2025

The biotech firm accelerates clinical trials for TN-201 and TN-401, targeting genetic heart disease

Europe’s first 100m consumer health fund targets proactive care revolution

Europe’s first 100m consumer health fund targets proactive care revolution

Longevity Technology - 18-Feb-2025

naturalX backs startups reshaping wellness and prevention

Mair Therapeutics targets Parkinson’s with AI-driven drug discovery

Mair Therapeutics targets Parkinson’s with AI-driven drug discovery

Longevity Technology - 17-Feb-2025

The Dutch startup is using ion channel research and advanced tech to develop new treatments

Junevity secures $10m to pioneer “cell reset” therapies for longevity

Junevity secures $10m to pioneer “cell reset” therapies for longevity

Longevity Technology - 13-Feb-2025

Backed by AI and genetics, Junevity targets age-related diseases


Display all articles